Appendix 4E Preliminary Final Report

Name of entity Analytica Limited

ABN 12 006 464 866

  1. Reporting Period

    Report for the financial year end

    30 June 2016

    Previous corresponding reporting period

    30 June 2015

  2. Results for announcement to the market

    $

    Percentage increase/(decrease) over previous corresponding period

    Revenue from ordinary activities

    2,116,242

    89

    Profit/(loss) from ordinary activities after tax attributable to members

    (4,002,331)

    (25)

    Net profit/(loss) for the period attributable to members

    (4,002,331)

    (25)

    Dividends

    Amount per security

    Franked amount per security

    Final dividend

    Nil

    Nil

    Interim dividend

    Nil

    Nil

    Record date for determining entitlements to dividend

    Not applicable

    Brief explanation of any of the figures reported above necessary to enable the figures to be understood

    The increase in revenue is increased R&D tax incentive received due to increased investment in R&D in 2015. Market development activity peaked in calendar 2015 and has reduced in 2016 calendar year.

  3. Income

    Statement Refer to Attachment A These accounts are in the process of being audited.
  4. Balance Sheet Refer to Attachment A These accounts are in the process of being audited.

  5. Statement of Changes in Equity

  6. Cash Flow Statement

    Refer to Attachment A These accounts are in the process of being audited.

    Refer to Attachment A These accounts are in the process of being audited.

  7. Dividends

    Date dividend is payable

    Not applicable

    Record date to determine entitlement to the dividend

    Not applicable

    Amount per security

    Not applicable

    Total dividend

    Not applicable

    Amount per security of foreign sourced dividend or distribution

    Not applicable

    Details of any dividend reinvestment plans in operation

    Not applicable

    The last date for receipt of an election notice for participation in any dividend reinvestment plans

    Not applicable

  8. Statement of retained earnings

    Consolidated Entity

    2016

    2015

    Balance at the beginning of the year

    (92,268,467)

    (86,952,863)

    Net profit attributable to members of the parent entity

    (4,0002.331)

    (5,316,604)

    Transfer from option reserve

    Balance at end of the year

    (96,270,798)

    (92,268,467)

  9. Net tangible assets per security

    Current period

    Previous corresponding period

    Net tangible asset backing per ordinary security

    0.05 cents

    0.05 cents

  10. Details of entities over which control has been gained or lost during the period

    Not applicable

  11. Details of associated and joint venture entities

Name of associate or joint venture entity

% Securities held

PeriCoach Pty Ltd

100

Analytica Limited published this content on 31 August 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 31 August 2016 04:08:07 UTC.

Original documenthttp://www.analyticamedical.com/downloads/2016/20160831-ASX-ALT-Appendix4E.pdf

Public permalinkhttp://www.publicnow.com/view/A9A7F0AE7816B8A126D742BED0C83692A8AF99A4